1. McGuire LC, Cruickshank AM, Munro PT. Alcoholic ketoacidosis. Emerg Med J. 2006; 23:417–420.
Article
2. Kraut JA, Kurtz I. Toxic alcohol ingestions: Clinical features, diagnosis, and management. Clin J Am Soc Nephrol. 2008; 3:208–225.
Article
3. Lee JW, Yang SJ, Jin SC, Joo MD, Choi WI. The prognostic factors for alcoholic ketoacidosis. J Korean Soc Emerg Med. 2009; 20:86–94.
4. Wrenn KD, Slovis CM, Minion GE, Rutkowski R. The syndrome of alcoholic ketoacidosis. Am J Med. 1991; 91:119–128.
Article
5. Palmiere C, Augsburger M. The postmortem diagnosis of alcoholic ketoacidosis. Alcohol Alcohol. 2014; 49:271–281.
Article
6. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system--a review. Alcohol Clin Exp Res. 1998; 22:1927–1942.
Article
7. Seok Y, Choi JR, Kim J, Kim YK, Lee J, Song J, et al. Delta neutrophil index: A promising diagnostic and prognostic marker for sepsis. Shock. 2012; 37:242–246.
8. Nahm CH, Choi JW, Lee JW. Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis. Ann Clin Lab Sci. 2008; 38:241–246.
9. Ahn CW, Kim WH, Lim TH, Cho Ys, Choi KS, Jang BH. The delta neutrophil index (DNI) as a prognostic marker for mortality in adults with sepsis: A systematic review and meta-analysis. Sci Rep. 2018; 8:6621.
Article
10. Park BH, Kang YA, Park MS, Jung WJ, Lee SH, Lee SK, et al. Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis. 2011; 11:299.
Article
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med. 1985; 13:818–829.
12. Kratz A, Maloum K, O'Malley C, Zini G, Rocco V, Zelmanovic D, et al. Enumeration of nucleated red blood cells with the ADVIA 2120 Hematology System: An International Multicenter Clinical Trial. Lab Hematol. 2006; 12:63–70.
Article
13. Harris N, Jou JM, Devoto G, Lotz J, Pappas J, Wranovics D, et al. Performance evaluation of the ADVIA 2120 hematology analyzer: An international multicenter clinical trial. Lab Hematol. 2005; 11:62–70.
Article
14. Noor NM, Basavaraju K, Sharpstone D. Alcoholic ketoacidosis: A case report and review of the literature. Oxf Med Case Reports. 2016; 2016:31–33.
Article
15. Halperin ML, Hammeke M, Josse RG, Jungas RL. Metabolic acidosis in the alcoholic: A pathophysiologic approach. Metabolism. 1983; 32:308–315.
Article
16. Romeo J, Warnberg J, Nova E, Diaz LE, Gomez-Martinez S, Marcos A. Moderate alcohol consumption and the immune system: A review. 98 Supp. Br J Nutr. 2007; 98:Suppl 1. S111–S115.
17. Gamble L, Mason CM, Nelson S. The effects of alcohol on immunity and bacterial infection in the lung. Med Mal Infect. 2006; 36:72–77.
18. Zhang P, Bagby GJ, Happel KI, Raasch CE, Nelson S. Alcohol abuse, immunosuppression, and pulmonary infection. Curr Drug Abuse Rev. 2008; 1:56–67.
Article
19. Laso FJ, Madruga JI, Lopez A, Ciudad J, Alvarez-Mon M, San Miguel J, et al. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period. Alcohol Clin Exp Res. 1997; 21:672–676.
Article
20. Laso FJ, Madruga JI, San Miguel JF, Ciudad J, Lopez A, Alvarez Mon M, et al. Long lasting immunological effects of ethanol after withdrawal. Cytometry. 1996; 26:275–280.
Article
21. Lindroos-Jokinen K, Keltanen T, Vanhala T, Valonen T, Sajantila A. Postmortem measurement of C-reactive protein and interpretation of results in ketoacidosis. Leg Med (Tokyo). 2012; 14:140–146.
Article
22. Jain SK, McVie R, Bocchini JA Jr. Hyperketonemia (ketosis), oxidative stress and type 1 diabetes. Pathophysiology. 2006; 13:163–170.
Article
23. Kellum JA, Song M, Li J. Science review: extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care. 2004; 8:331–336.
24. Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol. 2001; 69:522–530.
25. De Marchi S, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E. Renal tubular dysfunction in chronic alcohol abuse--effects of abstinence. N Engl J Med. 1993; 329:1927–1934.
Article
26. Zhou C, Byard RW. Basal renal tubular epithelial cell vacuolization and alcoholic ketoacidosis. J Forensic Sci. 2012; 57:126–128.
Article
27. Kellum JA, Song M, Venkataraman R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest. 2004; 125:243–248.
Article
28. Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010; 6:274–285.
Article
29. Yu J, Shin Y, Jung HJ, Yun YS, Kim HG, Kim YS, et al. Clinical characteristics and risk factors of acute kidney injury in patients with acute alcohol intoxication. Korean J Nephrol. 2011; 30:26–34.
30. Tran DD, Groeneveld AB, van der Meulen J, Nauta JJ, Strack van Schijndel RJ, Thijs LG. Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit Care Med. 1990; 18:474–479.
Article
31. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg. 1992; 216:117–134.
Article
32. Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham EL, et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med. 2003; 31:869–877.
Article
33. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s - Systemic inflammatory response and organ dysfunction. JAMA. 1994; 271:226–233.
Article